Cancer Biomarkers

A cancer biomarker refers to an element or procedure that is indicative of the presence of cancer in the body. A biomarker may be a molecule released by a presence of tumour or a specific response of the body to the presence of cancer. Cancer biomarkers are usually biological molecules found in blood, other body fluids, or tissues that are a sign of a normal or abnormal process, or of a condition or disease. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis and epidemiology. The most promising use of biomarkers today is to identify which therapies a patient’s cancer may or may not respond to. So many pharmaceutical companies were producing different sort of biomarkers. So it plays a vital role in the treatment in cancer.

  • Types of Cancer Biomarkers
  • Biomarkers in Drug Discovery
  • Biomarkers in Cancer Screening
  • Biomarkers in Pharmacokinetics
  • Biomarkers in Pharmacodynamics

Related Conference of Cancer Biomarkers

June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 24-25, 2024

7th International Conference on Anti-Cancer Drugs

Vancouver, Canada

Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in